“We were instrumental in bringing Brent on board as the new CEO of Forest Labs a few years ago and worked cooperatively and constructively with him to help increase value for all Forest shareholders,” Icahn said on his website. “Less than a year later Forest was acquired by Actavis (which subsequently merged with Allergan) resulting in massive gains for Forest shareholders. While we at that time disposed of our position in Forest, we still have always maintained great respect for Brent.”
Allergan did not immediately respond to CNBC’s request for comment.
Click here for the latest on the markets.
— Reporting by CNBC’s Steven Kopack and Jim Forkin.